TABLE 3.
Amylase and Lipase Serum Activities in Patients With Different O2 Support
| No. Patients | Mean (SD) | Range | P | |
|---|---|---|---|---|
| Amylase, IU/L | 0.046 | |||
| No O2 support | 7 | 31.9 (20.1) | 6.6–70.9 | |
| Ventimask | 42 | 36.3 (25.0) | 4.9–161.3 | |
| CPAP | 41 | 56.1 (45.7) | 8.9–265.6 | |
| NIMV | 20 | 50.0 (28.3) | 19.3–113.8 | |
| Total | 110 | 45.9 (35.4) | 4.9–265.6 | |
| Lipase, IU/L | 0.065 | |||
| No O2 support | 7 | 119.9 (69.3) | 12.0–205.0 | |
| Ventimask | 42 | 131.7 (82.74) | 16.0–433.0 | |
| CPAP | 41 | 258.1 (348.8) | 24.0–2175.0 | |
| NIMV | 20 | 236.0 (173.1) | 23.0–646.0 | |
| Total | 110 | 197.0 (237.5) | 12.0–2175.0 |
CPAP indicates continuous positive airway pressure; NIMV, noninvasive mechanical ventilation.